Clinical significance and predicting indicators of post-cancer-treatment survival in terminally ill patients with ovarian cancer

Fumi Utsumi, Hiroaki Kajiyama, Kaoru Niimi, Ryuichiro Sekiya, Jun Sakata, Shiro Suzuki, Kiyosumi Shibata, Mika Mizuno, Fumitaka Kikkawa

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

Aim: Women with ovarian cancer (OC) often experience relapse and receive further repetitive chemotherapy. The objective of this study was to overview the remaining survival time after the final chemotherapy and to examine influential clinicopathologic indicators in those patients. Methods: The medical charts of deceased OC patients who had died of the disease between 2003 and 2012 were retrospectively reviewed. We investigated post-cancer-treatment survival (PCS) defined as the interval between the date of the final chemotherapy and death. Results: In all, 77 patients were enrolled. Three patients (3.9%) had received chemotherapy in the last 2 weeks. Eight (10.4%), 28 (36.4%), and 44 (57.2%) patients had received chemotherapy in the last 30, 60, and 90 days, respectively. There were no differences in either survival after recurrence or overall survival between the shorter (<75 days) and longer (≥75 days) PCS groups. On the other hand, patients in the shorter PCS group had significantly fewer chances of referral to a hospice or home-care than those in the latter group (P = 0.035). In multivariable analysis, a poorer performance status, an elevated white blood cell count, and a higher C-reactive protein value were significantly correlated with a shorter PCS (P = 0.004, 0.006 and 0.027, respectively). Conclusion: Half of the patients received chemotherapy within 75 days of death and we did not identify any survival benefit in patients who received chemotherapy near the end of life. We should provide information to patients about their prognosis and discuss the timing of withdrawal from chemotherapy from the early stage of their recurrence.

Original languageEnglish
Pages (from-to)365-370
Number of pages6
JournalJournal of Obstetrics and Gynaecology Research
Volume43
Issue number2
DOIs
Publication statusPublished - 01-02-2017
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynaecology

Fingerprint

Dive into the research topics of 'Clinical significance and predicting indicators of post-cancer-treatment survival in terminally ill patients with ovarian cancer'. Together they form a unique fingerprint.

Cite this